Fifty-Two-Week Results of Clinical and Imaging Assessments of a Patient with Rheumatoid Arthritis Complicated by Systemic Sclerosis with Interstitial Pneumonia and Type 1 Diabetes despite Multiple Disease-Modifying Antirheumatic Drug Therapy That Was Successfully Treated with Baricitinib: A Novel Case Report

Baricitinib is a Janus kinase 1/2 (JAK1/2) inhibitor used in the treatment of rheumatoid arthritis. A 71-year-old woman with rheumatoid arthritis complicated by systemic sclerosis and type 1 diabetes that were resistant to multiple disease-modifying antirheumatic drugs started treatment with baricit...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujita, Yuya, Nawata, Masao, Nagayasu, Atsushi, Someya, Kazuki, Saito, Kazuyoshi, Tanaka, Yoshiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6652034/
https://www.ncbi.nlm.nih.gov/pubmed/31360575
http://dx.doi.org/10.1155/2019/5293981

Ejemplares similares

Ejemplares similares